Virgin Coconut Oil as Adjunctive Therapy for Hospitalized COVID-19 Patients

Virgin Coconut Oil as Adjunctive Therapy for Hospitalized COVID-19 Patients

This is a research that will investigate the safety and efficacy of virgin coconut oil (VCO) as an adjunctive therapy for Coronavirus Disease 2019 (COVID-19)

This study will be a randomized controlled trial among hospitalized COVID-19 patients, aged 18 years old and above, admitted at the Philippine General hospital. Patients will be grouped into the following:

1. Group receiving standard of care
2. Group receiving standard of care plus virgin coconut oil (15ml, 3x/day for 2 weeks) as adjunctive therapy.

Patients will be observed as regards to primary outcomes such as recovery/resolution of symptoms and duration of hospital stay

Inclusion Criteria:

• symptomatic and asymptomatic COVID-19 hospitalized patients
• has laboratory-confirmed illness during the time of recruitment
• able to take food and medicines enterally

Exclusion Criteria:

• uncontrolled or newly diagnosed diabetes mellitus
• with chronic heart disease
• having elevated lipid profile at baseline (admission)